SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches ...
Timing is critical in diagnosing diseases such as cancer. Researchers within The Grainger College of Engineering at the ...
Yesterday, the U.S. Food and Drug Administration approved the first blood-based genetic test that can detect gene mutations in non-small cell lung cancer patients. The cobas EGFR Mutation Test v2 is a ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years before it’s spotted by doctors for an official diagnosis. As detailed in a ...
BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk ...
The Chosun Ilbo on MSN
CaniCatiCare launches precision cancer diagnostics for companion dogs
A startup recently gained attention for commercializing a multiplex PCR (gene amplification) test technology to detect cancer ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results